Pharm-Bio Building Boom: More than $20 Billion Set for 2014 North American Capital Project Starts
Attachment: Pharma-Bio 2014
SUGAR LAND--January 17, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--It would be a hard to say just what the true health of the economy is today, with so many conflicting reports. With the general financial forecast still gyrating between growth and despair, it is gratifying to offer some positive news from the Pharmaceutical-Biotech Industry. According to a recent analysis of Industrial Info's Pharmaceutical Tracker - Online Database, a projected $20.8 billion in active reported projects are scheduled to begin construction in 2014, allocated among 720 active capital and maintenance, repair and operations (MRO) projects.
Other companies featured: AECOM (NYSE:ACM), Bristol-Myers Squibb (NYSE:BMY)
